Intelligence coverage: 55%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

LRMR

Larimar Therapeutics, Inc.

Healthcare · Pharmaceutical Preparations

$3.14Sep 29, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Limited proprietary earnings coverage for LRMR yet — signals will sharpen as filings and earnings are ingested.

Pipeline evidence · 17d ago

LRMR's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on LRMR.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest Intelligence

Updated

What happened recently for Larimar Therapeutics, Inc. (LRMR) — events, not interpretation.

Event
Last session September 29, 2026 at $3.14.
Source
Market data

Research & analysis only — not investment advice.

Building company intelligence…

Larimar Therapeutics, Inc. (LRMR)

Healthcare · Pharmaceutical Preparations

Investment Snapshot above is the primary AlphaOS analysis for Larimar Therapeutics, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Market cap:
$326.19M
Revenue:
$0

LRMR earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Larimar Therapeutics, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.